SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-028662
Filing Date
2021-12-15
Accepted
2021-12-15 16:11:52
Documents
15
Period of Report
2021-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20211214_8k.htm   iXBRL 8-K 29021
2 EXHIBIT 99.1 ex_316540.htm EX-99.1 16218
7 gv01.jpg GRAPHIC 5798
  Complete submission text file 0001437749-21-028662.txt   207471

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20211215.xsd EX-101.SCH 4030
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20211215_def.xml EX-101.DEF 13402
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20211215_lab.xml EX-101.LAB 17563
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20211215_pre.xml EX-101.PRE 13373
8 EXTRACTED XBRL INSTANCE DOCUMENT govx20211214_8k_htm.xml XML 4275
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 211494341
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences